Has there been any recent news about Neurontin?
On January 31, 2008, the U.S. Food and Drug Administration (FDA) issued a warning about an increased risk of suicidal thoughts and behaviors (suicidality) in patients who take drugs called antiepileptics to treat epilepsy, bipolar disorder, migraine headaches, and other conditions. The drugs that are subject to the warning include Neurontin. FDA analysis of recent studies showed patients taking antiepileptics had about twice the risk of suicidal thoughts and behaviors, compared with patients receiving placebo. A number of lawsuits have been filed alleging that Neurontin causes suicidal or suicidal thoughts (called “suicidality”). Plaintiffs in these cases allege that Neurontin-maker Pfizer Pharmaceuticals failed to disclose the risk of suicidality. In 2004, Pharmaceutical manufacturer Warner-Lambert, a subsidiary of Pfizer Pharmaceuticals, agreed to plead guilty and to pay more than $430 million to resolve criminal charges and civil liability, in connection with the illegal and fraudul
